GLP1R and type 2 diabetes mellitus: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent a group of antidiabetic medications that have recently gained attention as a promising therapeutic approach for renal and CV conditions in individuals living with T2DM, which are also used in some cases to treat obesity [5].